 |
PDBe Entry: 1d4k 
HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR
 |
HYDROLASE
|
|
X-RAY DIFFRACTION
|
|
Resolution: 1.85 Å, R-factor: 21.19%, Free R-factor: 25.9%, Spacegroup: P 21 21 21
|
|
11/10/2000, deposition: 04/10/1999, last revision: 24/02/2009
|
|
Tyndall, J.D.; Reid, R.C.; Tyssen, D.P.; Jardine, D.K.; Todd, B.; Passmore, M.; March, D.R.; Pattenden, L.K.; Alewood, D.; Hu, S.H.; Alewood, P.F.; Birch, C.J.; Martin, J.L.; Fairlie, D.P.
|
Synthesis, stability, antiviral activity, and protease-bound structures of substrate-mimicking constrained macrocyclic inhibitors of HIV-1 protease.
J.MED.CHEM. vol:43, pag:3495-3504 (2000) [PubMed ID 11000004 ]
|
|
HIV, PROTEASE, INHIBITOR, ANTIVIRAL, STRUCTURE, HYDROLASE
|
|
2.7.7.49 ExPASy BRENDA 2.7.7.7 ExPASy BRENDA 3.1.26.4 ExPASy BRENDA 3.4.23.16 ExPASy BRENDA (A B)
|
|
|
|
Gag-Pol polyprotein (Pr160Gag-Pol) [Contains: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide p2; Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (Retropepsin) (PR); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p66 RT); p51 RT; p15; Integrase (IN)] P03369 (A B)
|
|
A, B
|
|
1b6k, 1b6m
|
| A, B |
HIV-1 PROTEASE |
Protein |
P03369 (POL_HV1A2)
|
99 |
100% |
|
| A |
SULFATE ION |
SO4
|
| A |
N-13-[(10S,13S)-9,12-DIOXO-10-(2-BUTYL)-2-OXA-8,11-DIAZABICYCLO [13.2.2] NONADECA-15,17,18-TRIENE] (2R)-BENZYL-(4S)-HYDROXY-5-AMINOPENTANOIC (1R)-HYDROXY-(2S)-INDANEAMIDE |
PI8
|
|
|
